Cefazolin Sodium

Product NDC: 0264-3103
11-digit product format: 002643103
Labeler code: 0264
Product ID: 0264-3103_fb2f076a-22b3-46e0-86c8-7678e89c9edf
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefazolin Sodium
Dosage form: SOLUTION
Route: INTRAVENOUS
Labeler: B. Braun Medical Inc.
Application: NDA050779
Marketing category: NDA
Marketing start: 2000-07-27
Substance: CEFAZOLIN SODIUM
Active strength: 1 g/50mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0264-3103		D	Discontinued by firm		2026-08-17
excluded package	package	0264-3103	0264-3103-11	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0264-3103-11	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0264-3103-11	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0264-3103-11	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0264-3103-11	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0264-3103-11	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0264-3103-11	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0264-3103-11	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0264-3103-11	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0264-3103-11	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0264-3103-11	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0264-3103-11	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0264-3103-11	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N050779-001	CEFAZOLIN AND DEXTROSE	CEFAZOLIN SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27
N050779-002	CEFAZOLIN AND DEXTROSE	CEFAZOLIN SODIUM	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27
N050779-003	CEFAZOLIN AND DEXTROSE	CEFAZOLIN SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13
N050779-004	CEFAZOLIN AND DEXTROSE	CEFAZOLIN SODIUM	EQ 3GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2024-08-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 134 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N050779-004	CEFAZOLIN AND DEXTROSE	EQ 3GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2024-08-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050779-004	CEFAZOLIN AND DEXTROSE	EQ 3GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2024-08-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050779-004	CEFAZOLIN AND DEXTROSE	EQ 3GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2024-08-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050779-004	CEFAZOLIN AND DEXTROSE	EQ 3GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2024-08-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050779-004	CEFAZOLIN AND DEXTROSE	EQ 3GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2024-08-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050779-004	CEFAZOLIN AND DEXTROSE	EQ 3GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2024-08-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050779-004	CEFAZOLIN AND DEXTROSE	EQ 3GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2024-08-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050779-001	CEFAZOLIN AND DEXTROSE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION		2000-07-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050779-002	CEFAZOLIN AND DEXTROSE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	RLD, RS	2000-07-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050779-003	CEFAZOLIN AND DEXTROSE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	RLD	2012-01-13	`d06236e962d9…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2023-12-20 04:57 UTC	2023-12	N050779-001	NPP	2023-11-23	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	N050779-002	NPP	2023-11-23	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	N050779-003	NPP	2023-11-23	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N050779-001	NPP	2023-11-23	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N050779-002	NPP	2023-11-23	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N050779-003	NPP	2023-11-23	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N050779-001	NPP	2023-11-23	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N050779-002	NPP	2023-11-23	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N050779-003	NPP	2023-11-23	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N050779-001	NPP	2023-11-23	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N050779-002	NPP	2023-11-23	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N050779-003	NPP	2023-11-23	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N050779-001	NPP	2023-11-23	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N050779-002	NPP	2023-11-23	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N050779-003	NPP	2023-11-23	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N050779-001	NPP	2023-11-23	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	N050779-002	NPP	2023-11-23	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	N050779-003	NPP	2023-11-23	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N050779-001	NPP	2023-11-23	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N050779-002	NPP	2023-11-23	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N050779-003	NPP	2023-11-23	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N050779-001	NPP	2023-11-23	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N050779-002	NPP	2023-11-23	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N050779-003	NPP	2023-11-23	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N050779-001	NPP	2023-11-23	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N050779-002	NPP	2023-11-23	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N050779-003	NPP	2023-11-23	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N050779-001	NPP	2023-11-23	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N050779-002	NPP	2023-11-23	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N050779-003	NPP	2023-11-23	`e64feba35796…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefazolin Sodium
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFAZOLIN SODIUM	1 g/50mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
P380M0454Z	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1665050	Internal RxNorm lookup
1665060	Internal RxNorm lookup
2630753	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
17f8f038-c204-4dab-80d7-6f7ac41ddbec	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4c53c44d-0495-40c1-9f02-9d772dc7a5c7	Product name	1	20250318
53d47d5d-6076-4275-8f76-06d261cff1e8	Product name	1	20231011
9afe2d9a-f7f6-416b-9ddf-b780a2810bd5	Product name	1	20230912
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
6e62eeca-6666-f31f-9873-48ea9ede8354	Product name	2	20190214
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
afa25392-d76e-4453-8841-fde3a34824f1	Product name	2	20160309
53cae805-773b-4bc5-a836-3e22e250892e	Product name	1	20150922
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
05d4c919-c877-4ec4-cb08-9fcbbbfd8c70	Product name	1	20140508
75ba2549-0297-c880-16c8-4fa502c95a9d	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0264-3103-11	Cefazolin Sodium	50 mL in 1 CONTAINER	SOLUTION	50		31
0264-3103-11	Cefazolin Sodium	24 in 1 CASE	SOLUTION	24		31

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0264-3103-11	EA - Each	0264-3103	99b9362e-78e5-446c-859a-08238f115195	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFAZOLIN SODIUM	ACTIVE INGREDIENT	P380M0454Z	CEFAZOLIN SODIUM SOLUTION [B. BRAUN MEDICAL INC.]	9
CEFAZOLIN	ACTIVE MOIETY	IHS69L0Y4T	CEFAZOLIN SODIUM SOLUTION [B. BRAUN MEDICAL INC.]	9
DEXTROSE MONOHYDRATE	INACTIVE INGREDIENT	LX22YL083G	CEFAZOLIN SODIUM SOLUTION [B. BRAUN MEDICAL INC.]	9
WATER	INACTIVE INGREDIENT	059QF0KO0R	CEFAZOLIN SODIUM SOLUTION [B. BRAUN MEDICAL INC.]	9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0264-3103	CEFAZOLIN SODIUM SOLUTION [B. BRAUN MEDICAL INC.]	31	Current NDC, Legacy NDC, 2 package rows	20250410_17f8f038-c204-4dab-80d7-6f7ac41ddbec.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefazolin Sodium	CEFAZOLIN SODIUM	B. Braun Medical Inc.	17f8f038-c204-4dab-80d7-6f7ac41ddbec	2025-03-10	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050779 application number: NDA050779 ndc (product): 0264-3103

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
P380M0454Z	CEFAZOLIN SODIUM	27164-46-1	CEFAZOLIN SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1665050	ceFAZolin 1 GM Injection	PSN	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
1665060	ceFAZolin 2 GM Injection	PSN	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
2630753	ceFAZolin 3 GM Injection	PSN	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
1665050	cefazolin 1000 MG Injection	SCD	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
1665060	cefazolin 2000 MG Injection	SCD	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
2630753	cefazolin 3000 MG Injection	SCD	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
1665060	cefazolin (as cefazolin sodium) 2 GM Injection	SY	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
2630753	cefazolin (as cefazolin sodium) 3 GM Injection	SY	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
1665050	cefazolin 1 GM (as cefazolin sodium) Injection	SY	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31
1665050	cefazolin 1 GM Injection	SY	17f8f038-c204-4dab-80d7-6f7ac41ddbec	31

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0264-3103-11	00264310311	24 CONTAINER in 1 CASE (0264-3103-11) / 50 mL in 1 CONTAINER	24 container	2000-07-27	0000-00-00	No	No	Current